Mirae Asset Global Investments
SGMO

Mirae Asset Global Investments’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Mirae Asset Global Investments’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-493,431
Closed -$839K – 2361
2024
Q1 		$839K Buy
+493,431
New +$358K ﹤0.01% 1634
2023
Q4 		– Sell
-676,189
Closed -$406K – 2591
2023
Q3 		$406K Buy
676,189
+62,465
+10% +$66.9K ﹤0.01% 1989
2023
Q2 		$798K Buy
613,724
+88,444
+17% +$121K ﹤0.01% 1701
2023
Q1 		$924K Buy
525,280
+27,974
+6% +$79.8K ﹤0.01% 1583
2022
Q4 		$1.56M Sell
497,306
-138,488
-22% -$537K ﹤0.01% 1276
2022
Q3 		$3.12M Buy
635,794
+82,067
+15% +$422K 0.01% 964
2022
Q2 		$2.29M Buy
553,727
+169,334
+44% +$732K 0.01% 1106
2022
Q1 		$2.23M Sell
384,393
-70,884
-16% -$421K ﹤0.01% 1123
2021
Q4 		$3.42M Buy
455,277
+95,599
+27% +$830K 0.01% 980
2021
Q3 		$3.24M Buy
359,678
+56,576
+19% +$559K 0.01% 975
2021
Q2 		$3.63M Buy
303,102
+40,100
+15% +$454K 0.01% 903
2021
Q1 		$3.3M Buy
263,002
+119,168
+83% +$1.61M 0.01% 835
2020
Q4 		$2.24M Buy
143,834
+33,119
+30% +$388K 0.01% 883
2020
Q3 		$1.05M Buy
110,715
+35,747
+48% +$387K 0.01% 953
2020
Q2 		$672K Buy
74,968
+26,902
+56% +$250K ﹤0.01% 1046
2020
Q1 		$306K Buy
48,066
+5,257
+12% +$39K ﹤0.01% 1198
2019
Q4 		$358K Buy
42,809
+10,312
+32% +$94.8K ﹤0.01% 1314
2019
Q3 		$294K Buy
+32,497
New +$365K ﹤0.01% 1318

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mirae Asset Global Investments's SGMO Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2024, closing a stake of 493,431 shares — an estimated $839K sold.

Mirae Asset Global Investments first reported a position in SGMO in Q3 2019 and held it in 18 quarters. The position peaked at $3.63M in Q2 2021. 129 funds tracked by Wall St. Rank hold SGMO as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 493,431 SANGAMO THERAPEUTICS INC shares in Q2 2024, an estimated $839K.
  • Mirae Asset Global Investments first reported a position in SANGAMO THERAPEUTICS INC in Q3 2019 and held it in 18 quarters.
  • Mirae Asset Global Investments's SANGAMO THERAPEUTICS INC position peaked at $3.63M in Q2 2021.
  • 129 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.